Skip to main content

Advertisement

Table 2 Fatty acid profile of food in control and AD* patients

From: The sociodemographic characteristics and dietary and blood plasma fatty acid profiles of elderly Saudi women with Alzheimer disease

Fatty acid from Food (g/day) National Guard Health Affairs- King Abdulaziz Medical City, Riyadh (NGH) Social Welfare Homes for the Elderly (SWH)
  Control Alzheimer Control Alzheimer
LA (Linoleic acid; C18:2) 31.77 ± 2.902Aa 25.21 ± 2.221Bb 30.80 ± 3.0319Aa 26.34 ± 2.0249Bb
AA (Arachidonic acid; C20:4) 0.081 ± 0.006Aab 0.067 ± 0.0015Bb 0.077 ± 0.0022Aab 0.089 ± 0.0060Aa
ALA (α-linolenic acid; C18:3) 0.924 ± 0.0103Aa 0.816 ± 0.0240Aa 0.920 ± 0.0105Aa 0.844 ± 0.0216Aa
EPA (Eicosapentaenoic acid; C20:5) 0.050 ± 0.0051Aab 0.023 ± 0.0017Bb 0.071 ± 0.0075Aa 0.052 ± 0.0046Aab
DHA (Docosahexaenoic acid; C22:6) 0.012 ± 0.0005Aa 0.007 ± 0.0005Ba 0.013 ± 0.0006Aa 0.013 ± 0.0014Aa
Total ω-6 31.85 ± 2.908Aa 25.27 ± 6.23Bb 30.87 ± 3.0332Aa 26.43 ± 2.0265Bb
Total ω-3 0.986 ± 0.0117Aa 0.846 ± 0.0260Bb 1.002 ± 0.0126Aa 0.909 ± 0.0253Aab
ω-6/ ω-3 32.30 ± 2.279Aa 29.86 ± 2.552Aa 30.80 ± 3.0893Aa 29.075 ± 2.0848Aa
  1. *AD-Alzheimer disease; Results are reported in mean ± standard deviation
  2. abDifferent superscripts denote a statistically significant difference between controls of two different places and between Alzheimer patients of two places
  3. ABDifferent superscripts denote a statistically significant difference between controls and Alzheimers patients of each place individually